Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 5
Submit an article Journal homepage
340
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

Simon J. HarrisonSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, AustraliaCorrespondence[email protected]
,
Andy K. HsuSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
,
Paul NeesonSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
,
Anas YounesThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Anna SuredaHaematology Department, Addenbrooke's Hospital, Cambridge, UK;Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
,
Andreas EngertHospital of the University of Cologne, Cologne, Germany
,
H. Miles PrinceSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
,
Martha LiNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Paula SavageNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Roberto BugariniNovartis Institute for BioMedical Research, Cambridge, MA, USA
,
Denise WilliamsNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Margaret SquierNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
&
David S. RitchieSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
 show all
Pages 1053-1060 | Received 27 Feb 2013, Accepted 23 Jun 2013, Published online: 05 Aug 2013

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Luca Castagna, Armando Santoro & Carmelo Carlo-Stella. (2020) Salvage Therapy for Hodgkin’s Lymphoma: A Review of Current Regimens and Outcomes. Journal of Blood Medicine 11, pages 389-403.
Read now
Melita Cirillo & Sven Borchmann. (2020) An update on disease biomarkers for Hodgkin lymphoma. Expert Review of Hematology 13:5, pages 481-488.
Read now

Articles from other publishers (9)

Wael Khair. (2021) Is thymus and activation-regulated chemokine a forgotten diagnostic and minimal residual disease marker in classical Hodgkin lymphoma?. memo - Magazine of European Medical Oncology 14:4, pages 406-411.
Crossref
Simonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, Francesca Taverna, Andrea Rossi, Caterina Patti, Alessandra Romano, Livio Trentin, Roberto Sorasio, Anna Guidetti, Daniela Gottardi, Corrado Tarella, Michele Cimminiello, Roberta Zanotti, Lucia Farina, Andrés José Maria Ferreri, Marina Galbiati, Paolo Corradini, Alessandro Massimo Gianni, Andrea Gallamini & Alessandro Rambaldi. (2020) Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET ‐adapted strategy . Hematological Oncology 38:4, pages 501-508.
Crossref
Lydia Visser, Arjan Diepstra, Christian Steidl & Anke van den Berg. 2018. Precision Molecular Pathology of Hodgkin Lymphoma. Precision Molecular Pathology of Hodgkin Lymphoma 59 90 .
Alison J. Moskowitz, Heiko SchöderSomali Gavane, Katie L. Thoren, Martin Fleisher, Joachim Yahalom, Susan J. McCall, Briana R. Cadzin, Stephanie Y. Fox, John Gerecitano, Ravinder GrewalPaul A. Hamlin, Steven M. Horwitz, Anita Kumar, Matthew Matasar, Andy Ni, Ariela Noy, M. Lia Palomba, Miguel-Angel Perales, Carol S. Portlock, Craig Sauter, David Straus, Anas Younes, Andrew D. Zelenetz & Craig H. Moskowitz. (2017) Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma. Blood 130:20, pages 2196-2203.
Crossref
Antonino Carbone & Anas YounesCatherine Diefenbach & Christian Steidl. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2) 20 34 .
Francesca Montanari & Catherine Diefenbach. (2014) Relapsed Hodgkin Lymphoma: Management Strategies. Current Hematologic Malignancy Reports 9:3, pages 284-293.
Crossref
Y Oki, D Buglio, J Zhang, Y Ying, S Zhou, A Sureda, D Ben-Yehuda, P L Zinzani, H M Prince, S J Harrison, M Kirschbaum, P B Johnston, A Shen, B von Tresckow & A Younes. (2014) Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression. Blood Cancer Journal 4:8, pages e236-e236.
Crossref
Yasuhiro Oki. (2014) Use of panobinostat in patients with classical Hodgkin lymphoma. International Journal of Hematologic Oncology 3:3, pages 203-210.
Crossref
Catherine Diefenbach & Ranjana Advani. (2014) Customized Targeted Therapy in Hodgkin Lymphoma. Hematology/Oncology Clinics of North America 28:1, pages 105-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.